Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro

Detalhes bibliográficos
Autor(a) principal: Ledur, Pauline Christ
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
dARK ID: ark:/26339/001300000znp3
Texto Completo: http://repositorio.ufsm.br/handle/1/17398
Resumo: Pythiosis is a severe disease caused by the Oomycete Pythium insidiosum which can affect animals and humans. If not diagnosed and immediately treated, pythiosis can lead the affected host to death. Pythiosis treatment is difficult since it does not respond well to drugs commonly used in fungal diseases due to the lack of ergosterol in P. insidiosum cell wall. Due to this difficulty in pythiosis treatment with drugs, a therapeutic approach that is being successfully used is immunotherapy. The most accepted hypothesis to explain immunotherapy success is that they can switch host’s immune response from a Th2 to a Th1 response, with IFN-γ and IL-2 production, which activate mononuclear cells mediators as an immune response composed of T lymphocytes and macrophages which destroy P. insidiosum hyphae. A therapeutic approach that is gaining importance is the use of dendritic cells (DCs) as adjuvant, since DCs are capable of prime a strong cellular response. In this scenario, the aim of this study was to evaluate the stimulatory and immunomodulatory effects of DCs pulsed with different P. insidiosum antigens in human Th response in vitro. Peripheral blood monocytes were differentiated into DCs, which were pulsed with the immunotherapeutic PitiumVac®, β-glucans extracted from P. insidiosum cell wall, and Heat-inactivated (HI) zoospore. After sensitization, DCs pulsed with the tested antigens were co-cultured with lymphocytes for 24 hours and the supernatant was used to quantify the Th1, Th2 and Th17 cytokines produced. We also analyzed the proliferative rate of lymphocytes cultured with the pulsed DCs after 72 hours of incubation. Our results showed that DCs pulsed with P. insidiosum HI zoospores, β-glucans and the immunotherapeutic PitiumVac® efficiently induced T cell differentiation in a Th1 phenotype by the activation of specific Th1 cytokines production in vitro. HI zoospores showed the highest Th1 response among the tested groups, with a significant increase in IL-6 and IFN-γ production. These results suggest a potential use of DCs pulsed with P. insidiosum heat-inactivated zoospores as a new therapeutic strategy in the treatment and acquisition of immunity against pythiosis.
id UFSM_e005771efb68d067c3fe9c169d1c6b71
oai_identifier_str oai:repositorio.ufsm.br:1/17398
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitroImmunomodulatory activity of dendritic cells pulsed with different P. insidiosum antigens on cellular response in vitroPitioseImunoterapiaCélulas dendríticasPythium insidiosumβ-glucanasPythiosisImmunotherapyDendritic cellsPythium insidiosumβ-glucansCNPQ::CIENCIAS DA SAUDE::FARMACIAPythiosis is a severe disease caused by the Oomycete Pythium insidiosum which can affect animals and humans. If not diagnosed and immediately treated, pythiosis can lead the affected host to death. Pythiosis treatment is difficult since it does not respond well to drugs commonly used in fungal diseases due to the lack of ergosterol in P. insidiosum cell wall. Due to this difficulty in pythiosis treatment with drugs, a therapeutic approach that is being successfully used is immunotherapy. The most accepted hypothesis to explain immunotherapy success is that they can switch host’s immune response from a Th2 to a Th1 response, with IFN-γ and IL-2 production, which activate mononuclear cells mediators as an immune response composed of T lymphocytes and macrophages which destroy P. insidiosum hyphae. A therapeutic approach that is gaining importance is the use of dendritic cells (DCs) as adjuvant, since DCs are capable of prime a strong cellular response. In this scenario, the aim of this study was to evaluate the stimulatory and immunomodulatory effects of DCs pulsed with different P. insidiosum antigens in human Th response in vitro. Peripheral blood monocytes were differentiated into DCs, which were pulsed with the immunotherapeutic PitiumVac®, β-glucans extracted from P. insidiosum cell wall, and Heat-inactivated (HI) zoospore. After sensitization, DCs pulsed with the tested antigens were co-cultured with lymphocytes for 24 hours and the supernatant was used to quantify the Th1, Th2 and Th17 cytokines produced. We also analyzed the proliferative rate of lymphocytes cultured with the pulsed DCs after 72 hours of incubation. Our results showed that DCs pulsed with P. insidiosum HI zoospores, β-glucans and the immunotherapeutic PitiumVac® efficiently induced T cell differentiation in a Th1 phenotype by the activation of specific Th1 cytokines production in vitro. HI zoospores showed the highest Th1 response among the tested groups, with a significant increase in IL-6 and IFN-γ production. These results suggest a potential use of DCs pulsed with P. insidiosum heat-inactivated zoospores as a new therapeutic strategy in the treatment and acquisition of immunity against pythiosis.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESA pitiose é uma doença severa causada pelo Oomiceto Pythium insidiosum que acomete animais e humanos. Se não diagnosticada e tratada rapidamente, a pitiose pode levar à morte do indivíduo acometido. O tratamento da pitiose é difícil, visto que ela não responde bem aos fármacos comumente utilizados em doenças fúngicas, devido à ausência de ergosterol na membrana de P. insidiosum. Devido a essa dificuldade no tratamento da pitiose com fármacos, uma abordagem terapêutica que vem sendo utilizada com sucesso é a imunoterapia. A hipótese mais aceita para a eficácia dos imunoterápicos na pitiose, é que eles são capazes de favorecer uma mudança na resposta imune no hospedeiro de Th2 para Th1, com produção de IFN-γ e IL-2, o que causaria a ativação de mediadores de células mononucleares e consequente ativação de linfócitos T e macrófagos que destroem a hifa de P. insidiosum. Uma abordagem terapêutica que vem ganhando destaque é o uso de células dendríticas (DCs) como adjuvantes, visto que as DCs são capazes de induzir uma forte resposta imune celular. Neste cenário, o objetivo deste estudo foi avaliar o potencial aloestimulador e imunomodulador de células dendríticas pulsadas com diferentes antígenos de P. insidiosum sobre a resposta de células T humanas in vitro. Foram utilizadas DCs diferenciadas a partir de monócitos do sangue periférico humano, as quais foram sensibilizadas com o imunoterápico PitiumVac®, β- glucanas extraídas da parede de P. insidiosum e de zoósporos inativados por calor. Após a sensibilização com os antígenos, as DCs pulsadas foram co-cultivadas com linfócitos por 24 horas e realizou-se a quantificação das citocinas das respostas Th1, Th2 e Th17 a partir dos sobrenadantes celulares. Também foi analisada a proliferação dos linfócitos co-cultivados com as DCs sensibilizadas com os antígenos de P. insidiosum após 72 horas. Os resultados mostraram que DCs pulsadas com os zoósporos inativados por calor, as β-glucanas e o imunoterápico PitiumVac® eficientemente induzem a diferenciação das células T em um fenótipo Th, por meio da ativação de citocinas específicas da resposta Th1 in vitro. Os zoósporos inativados mostraram a maior resposta Th1 entre os grupos testados, com significativo aumento na produção das citocinas IL-6 e IFN-γ. Estes resultados sugerem um potencial uso de DCs pulsadas com zoósporos de P. insidiosum inativados por calor como uma nova estratégia terapêutica no tratamento e aquisição de imunidade contra a pitiose.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeSanturio, Janio Moraishttp://lattes.cnpq.br/6316012260769979Leal, Daniela Bitencourt Rosahttp://lattes.cnpq.br/3639683273462361Loreto, Érico Silva dehttp://lattes.cnpq.br/5475233864057995Ledur, Pauline Christ2019-07-10T19:39:18Z2019-07-10T19:39:18Z2016-03-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/17398ark:/26339/001300000znp3porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2019-07-11T06:01:47Zoai:repositorio.ufsm.br:1/17398Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2019-07-11T06:01:47Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
Immunomodulatory activity of dendritic cells pulsed with different P. insidiosum antigens on cellular response in vitro
title Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
spellingShingle Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
Ledur, Pauline Christ
Pitiose
Imunoterapia
Células dendríticas
Pythium insidiosum
β-glucanas
Pythiosis
Immunotherapy
Dendritic cells
Pythium insidiosum
β-glucans
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
title_full Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
title_fullStr Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
title_full_unstemmed Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
title_sort Atividade imunomoduladora de células dendríticas pulsadas com antígenos de Pythium insidiosum sobre a resposta celular in vitro
author Ledur, Pauline Christ
author_facet Ledur, Pauline Christ
author_role author
dc.contributor.none.fl_str_mv Santurio, Janio Morais
http://lattes.cnpq.br/6316012260769979
Leal, Daniela Bitencourt Rosa
http://lattes.cnpq.br/3639683273462361
Loreto, Érico Silva de
http://lattes.cnpq.br/5475233864057995
dc.contributor.author.fl_str_mv Ledur, Pauline Christ
dc.subject.por.fl_str_mv Pitiose
Imunoterapia
Células dendríticas
Pythium insidiosum
β-glucanas
Pythiosis
Immunotherapy
Dendritic cells
Pythium insidiosum
β-glucans
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Pitiose
Imunoterapia
Células dendríticas
Pythium insidiosum
β-glucanas
Pythiosis
Immunotherapy
Dendritic cells
Pythium insidiosum
β-glucans
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Pythiosis is a severe disease caused by the Oomycete Pythium insidiosum which can affect animals and humans. If not diagnosed and immediately treated, pythiosis can lead the affected host to death. Pythiosis treatment is difficult since it does not respond well to drugs commonly used in fungal diseases due to the lack of ergosterol in P. insidiosum cell wall. Due to this difficulty in pythiosis treatment with drugs, a therapeutic approach that is being successfully used is immunotherapy. The most accepted hypothesis to explain immunotherapy success is that they can switch host’s immune response from a Th2 to a Th1 response, with IFN-γ and IL-2 production, which activate mononuclear cells mediators as an immune response composed of T lymphocytes and macrophages which destroy P. insidiosum hyphae. A therapeutic approach that is gaining importance is the use of dendritic cells (DCs) as adjuvant, since DCs are capable of prime a strong cellular response. In this scenario, the aim of this study was to evaluate the stimulatory and immunomodulatory effects of DCs pulsed with different P. insidiosum antigens in human Th response in vitro. Peripheral blood monocytes were differentiated into DCs, which were pulsed with the immunotherapeutic PitiumVac®, β-glucans extracted from P. insidiosum cell wall, and Heat-inactivated (HI) zoospore. After sensitization, DCs pulsed with the tested antigens were co-cultured with lymphocytes for 24 hours and the supernatant was used to quantify the Th1, Th2 and Th17 cytokines produced. We also analyzed the proliferative rate of lymphocytes cultured with the pulsed DCs after 72 hours of incubation. Our results showed that DCs pulsed with P. insidiosum HI zoospores, β-glucans and the immunotherapeutic PitiumVac® efficiently induced T cell differentiation in a Th1 phenotype by the activation of specific Th1 cytokines production in vitro. HI zoospores showed the highest Th1 response among the tested groups, with a significant increase in IL-6 and IFN-γ production. These results suggest a potential use of DCs pulsed with P. insidiosum heat-inactivated zoospores as a new therapeutic strategy in the treatment and acquisition of immunity against pythiosis.
publishDate 2016
dc.date.none.fl_str_mv 2016-03-15
2019-07-10T19:39:18Z
2019-07-10T19:39:18Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/17398
dc.identifier.dark.fl_str_mv ark:/26339/001300000znp3
url http://repositorio.ufsm.br/handle/1/17398
identifier_str_mv ark:/26339/001300000znp3
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1815172419976953856